For this reason, suppressing Nrf2 expression through various inhibitory pathways such as siRNA technology and natural compounds (TPL, Wogonin, chaetominine) could help decrease drug resistance in CML. This evidence concerns the gene NFE2L2 and chronic myelogenous leukemia, BCR-ABL1 positive.